Blood News and Research

RSS

Researchers reveal possible role for anti-idiotype antibodies in long-term effects of COVID-19

With around 256 million cases and more than 5 million deaths worldwide, the COVID-19 pandemic has challenged scientists and those in the medical field.

25 Nov 2021

Physical activity may prevent accumulation of metabolic risk factors in menopausal women

A study conducted at the University of Jyväskylä in the Faculty of Sport and Health Sciences shows that menopausal transition is associated with unfavourable changes in metabolic health that may be mitigated with a physically active lifestyle. Especially, physical activity alleviated the increase in systolic blood pressure.

25 Nov 2021

International collaboration secures €1M grant to investigate new treatment target for lymphoma

An international collaboration involving researchers from Queen Mary University of London, Memorial Sloan Kettering Cancer Center, New York and Dana-Farber Cancer Institute, Boston has secured a €1M research grant from Dutch blood cancer charity, Lymph&Co, to investigate a new treatment target for lymphoma.

25 Nov 2021

Mapping cell structure by fusing protein images and interactions

If cells were "countries", the proteins would be their citizens organized into inter-connected towns and villages.

25 Nov 2021

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

Researchers measured anti-RBD IgG and virus neutralization before and after vaccination with boosters.

25 Nov 2021

Study shows vaccinated multiple myeloma patients at greater risk of breakthrough SARS-CoV-2 infections

Researchers recently published a study assessing the risks of patients with MM to breakthrough infections after completing their vaccination schedule compared to those without any form of cancer.

25 Nov 2021

Cerba Research Expands U.S. Immuno-Oncology Center of Excellence to Strengthen Its Precision Medicine Offerings

Cerba Research recently expanded. Our U.S. Immuno-Oncology Center of Excellence allows us to provide even more comprehensive, integrated central lab services, specialty lab and biomarker solutions, and diagnostic services worldwide.

From Cerba Research 25 Nov 2021

UVA researchers develop a noninvasive surgical approach to remove faulty brain circuits

University of Virginia School of Medicine researchers have developed a noninvasive way to remove faulty brain circuits that could allow doctors to treat debilitating neurological diseases without the need for conventional brain surgery.

25 Nov 2021

Serum SARS-CoV-2 antigen: A better predictor of COVID-19 severity

In this perspective, a new study published on the medRxiv* preprint server analyzed the clinical efficacy of two serum antigen tests to identify SARS CoV-2 infection and evaluate the kinetics of serum nucleocapsid (N) antigen in severe and non-severe patients for disease severity prediction.

24 Nov 2021

Innovative algorithm predicts COVID-related intensive care unit resource use

The COVID-19 pandemic is on the rise in many European countries, and hospitals world wide are under maximum pressure.

24 Nov 2021

Acute SARS-CoV-2 infection during pregnancy associated with placental ACE2 shedding

A new study, published on the bioRxiv* preprint server, hypothesized that ACE-2 expression and ADAM17 activity in the placenta is affected by the timing of SARS-CoV-2 infection of the mother.

24 Nov 2021

Drug-resistant bacteria are quickly outpacing new antibiotic development

Experts predict that without intervention, the problem of multidrug-resistant bacterial infections could be catastrophic by 2050, killing nearly 10 million people each year.

24 Nov 2021

Researchers analyze live bacteria from cystic lesions that are precursors to pancreatic cancer

Bacteria from the digestive system seem to have the potential to cause damage to pancreatic cells, increasing the risk of malignant tumors.

24 Nov 2021

Treatment with antihistamines associated with improved responses to immunotherapy

New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly used allergy medication, was associated with improved responses to immune checkpoint inhibitors.

24 Nov 2021

Research on psychedelics could lead to new treatments for mental illness

One in five U.S. adults will experience a mental illness in their lifetime, according to the National Alliance of Mental Health. But standard treatments can be slow to work and cause side effects.

24 Nov 2021

Study uncovers important genetic predispositions for acute myeloid leukemia

The National Center for Tumor Diseases Dresden is a joint institution of the German Cancer Research Center, the University Hospital Carl Gustav Carus Dresden, Carl Gustav Carus Faculty of Medicine at TU Dresden and the Helmholtz-Zentrum Dresden-Rossendorf.

24 Nov 2021

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

On November 23, 2021, the California Institute for Regenerative Medicine (CIRM) governing board approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.

24 Nov 2021

Blood News and Research

Researchers reveal possible role for anti-idiotype antibodies in long-term effects of COVID-19

Physical activity may prevent accumulation of metabolic risk factors in menopausal women

International collaboration secures €1M grant to investigate new treatment target for lymphoma

Mapping cell structure by fusing protein images and interactions

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

Study shows vaccinated multiple myeloma patients at greater risk of breakthrough SARS-CoV-2 infections

Cerba Research Expands U.S. Immuno-Oncology Center of Excellence to Strengthen Its Precision Medicine Offerings

UVA researchers develop a noninvasive surgical approach to remove faulty brain circuits

Serum SARS-CoV-2 antigen: A better predictor of COVID-19 severity

Innovative algorithm predicts COVID-related intensive care unit resource use

Acute SARS-CoV-2 infection during pregnancy associated with placental ACE2 shedding

Drug-resistant bacteria are quickly outpacing new antibiotic development

Researchers analyze live bacteria from cystic lesions that are precursors to pancreatic cancer

Treatment with antihistamines associated with improved responses to immunotherapy

Research on psychedelics could lead to new treatments for mental illness

Study uncovers important genetic predispositions for acute myeloid leukemia

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

Experimental compound reduces diabetic complications in mice

Exosomes involved in the progression of breast cancer in patients with obesity, diabetes

Antibody persistence in infants after maternal COVID-19 vaccination

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News